Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 10

Results: 32

In this issue: Volume 115, Issue 10, October 2024.

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3205, doi. 10.1111/cas.16358
Publication type:: Article

Correction to "ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood".

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3497, doi. 10.1111/cas.16318
Publication type:: Article

A highly sensitive reporter system to monitor endogenous YAP1/TAZ activity and its application in various human cells.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3370, doi. 10.1111/cas.16316

By:

Hikasa, Hiroki;
Kawahara, Kohichi;
Inui, Masako;
Yasuki, Yukichika;
Yamashita, Keita;
Otsubo, Kohei;
Kitajima, Shojiro;
Nishio, Miki;
Arima, Kazunari;
Endo, Motoyoshi;
Taira, Masanori;
Suzuki, Akira

Publication type:

Article

Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3248, doi. 10.1111/cas.16315

By:

Shigematsu, Yasuyuki;
Saito, Rumiko;
Amori, Gulanbar;
Kanda, Hiroaki;
Takahashi, Yu;
Takeuchi, Kengo;
Takahashi, Shunji;
Inamura, Kentaro

Publication type:

Article

Unlocking Japan's cervical cancer prevention deadlock.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3486, doi. 10.1111/cas.16311

By:

Tjalma, Wiebren A. A.

Publication type:

Article

Delta‐6 desaturase FADS2 is a tumor‐promoting factor in cholangiocarcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3346, doi. 10.1111/cas.16306

By:

Hasegawa, Kohsei;
Fujimori, Haruna;
Nakatani, Kohta;
Takahashi, Masatomo;
Izumi, Yoshihiro;
Bamba, Takeshi;
Nakamura‐Shima, Mao;
Shibuya‐Takahashi, Rie;
Mochizuki, Mai;
Wakui, Yuta;
Abue, Makoto;
Iwai, Wataru;
Fukushi, Daisuke;
Satoh, Kennichi;
Yamaguchi, Kazunori;
Shindo, Norihisa;
Yasuda, Jun;
Asano, Naoki;
Imai, Takayuki;
Asada, Yukinori

Publication type:

Article

RETRACTION: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor‐κB‐Induced Matrix Metalloproteinase 2 Expression.

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3491, doi. 10.1111/cas.16305
Publication type:: Article

A multicenter study on deep learning for glioblastoma auto‐segmentation with prior knowledge in multimodal imaging.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3415, doi. 10.1111/cas.16304

By:

Tian, Suqing;
Liu, Yinglong;
Mao, Xinhui;
Xu, Xin;
He, Shumeng;
Jia, Lecheng;
Zhang, Wei;
Peng, Peng;
Wang, Junjie

Publication type:

Article

Concerning trends and potential issues in osteosarcoma research publication.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3483, doi. 10.1111/cas.16303

By:

Horiuchi, Keisuke;
Chiba, Kazuhiro

Publication type:

Article

Correction to "P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5".

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3495, doi. 10.1111/cas.16301
Publication type:: Article

Multiplex plasma protein assays as a diagnostic tool for lung cancer.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3439, doi. 10.1111/cas.16300

By:

Ahamed, Mohammad Tanvir;
Forshed, Jenny;
Levitsky, Adrian;
Lehtiö, Janne;
Bajalan, Amanj;
Pernemalm, Maria;
Eriksson, Lars E.;
Andersson, Björn

Publication type:

Article

Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3333, doi. 10.1111/cas.16292

By:

Matsui, Yohei;
Yamada, Tadaaki;
Katayama, Yuki;
Hirai, Soichi;
Sawada, Ryo;
Tachibana, Yusuke;
Ishida, Masaki;
Kawachi, Hayato;
Nakamura, Ryota;
Nishioka, Naoya;
Morimoto, Kenji;
Iwasaku, Masahiro;
Horinaka, Mano;
Sakai, Toshiyuki;
Tokuda, Shinsaku;
Takayama, Koichi

Publication type:

Article

MGMT protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3394, doi. 10.1111/cas.16297

By:

Uchihara, Yoshinori;
Umeda, Katsutsugu;
Yamada, Yosuke;
Ito, Hiroaki;
Tasaka, Keiji;
Isobe, Kiyotaka;
Akazawa, Ryo;
Kawabata, Naoko;
Saida, Satoshi;
Kato, Itaru;
Hiramatsu, Hidefumi;
Noguchi, Takashi;
Sakamoto, Akio;
Arakawa, Yoshiki;
Arakawa, Ayumu;
Yamamoto, Nobuyuki;
Hosoya, Yosuke;
Uemura, Suguru;
Watanabe, Ken‐ichiro;
Sano, Hideki

Publication type:

Article

N‐acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3320, doi. 10.1111/cas.16296

By:

Sun, Luhaoran;
Li, Zeyu;
Shu, Peng;
Lu, Min

Publication type:

Article

Blocking CXCR4–CARM1–YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3305, doi. 10.1111/cas.16295

By:

Li, Zihua;
Lu, Hengli;
Zhang, Yiwei;
Lv, Jiyang;
Zhang, Yi;
Xu, Tianyang;
Yang, Dong;
Duan, Zhengwei;
Guan, Yonghao;
Jiang, Zongrui;
Liu, Kaiyuan;
Liao, Yuxin

Publication type:

Article

Which occurs first, ARID1A inactivation or microsatellite instability?: A comment to Yamamoto et al. (2024).

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3488, doi. 10.1111/cas.16294

By:

Lee, Dakeun

Publication type:

Article

Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B‐NIT).

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3231, doi. 10.1111/cas.16298

By:

Fujimoto, Takuya;
Yamasaki, Osamu;
Kanehira, Noriyuki;
Matsushita, Hirokazu;
Sakurai, Yoshinori;
Kenmotsu, Naoya;
Mizuta, Ryo;
Kondo, Natsuko;
Takata, Takushi;
Kitamatsu, Mizuki;
Igawa, Kazuyo;
Fujimura, Atsushi;
Otani, Yoshihiro;
Shirakawa, Makoto;
Shigeyasu, Kunitoshi;
Teraishi, Fuminori;
Togashi, Yosuke;
Suzuki, Minoru;
Fujiwara, Toshiyoshi;
Michiue, Hiroyuki

Publication type:

Article

Correction to inhibition of microRNA let‐7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3492, doi. 10.1111/cas.16291
Publication type:: Article

The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3288, doi. 10.1111/cas.16286

By:

Liu, Yuting;
Tang, Shing Chun;
Li, Chi Han;
To, Ka Fai;
Li, Bo;
Chan, Stephen Lam;
Wong, Chi Hin;
Chen, Yangchao

Publication type:

Article

Plasma cell‐free DNA methylome‐based liquid biopsy for accurate gastric cancer detection.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3426, doi. 10.1111/cas.16284

By:

Qi, Jian;
Hong, Bo;
Wang, Shujie;
Wang, Jingyun;
Fang, Jinman;
Sun, Ruifang;
Nie, Jinfu;
Wang, Hongzhi

Publication type:

Article

Spatial omics technologies for understanding molecular status associated with cancer progression.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3208, doi. 10.1111/cas.16283

By:

Nagasawa, Satoi;
Zenkoh, Junko;
Suzuki, Yutaka;
Suzuki, Ayako

Publication type:

Article

Interim PET‐guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced‐stage classic Hodgkin lymphoma (JCOG1305).

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3384, doi. 10.1111/cas.16281

By:

Kusumoto, Shigeru;
Munakata, Wataru;
Machida, Ryunosuke;
Terauchi, Takashi;
Onaya, Hiroaki;
Oguchi, Masahiko;
Iida, Shinsuke;
Nosaka, Kisato;
Suzuki, Yasuhiro;
Harada, Yasuhiko;
Miyazaki, Kana;
Maruta, Masaki;
Fukuhara, Noriko;
Toubai, Tomomi;
Kubota, Nobuko;
Ohmachi, Ken;
Saito, Toko;
Rai, Shinya;
Mizuno, Ishikazu;
Fukuhara, Suguru

Publication type:

Article

Newly developed humanized anti‐CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1‐CKAP4 signaling.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3358, doi. 10.1111/cas.16278

By:

Sada, Ryota;
Yamamoto, Hideki;
Matsumoto, Shinji;
Harada, Akikazu;
Kikuchi, Akira

Publication type:

Article

Correction to: AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA‐19a‐5p sponging in glioblastoma.

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3496, doi. 10.1111/cas.16277
Publication type:: Article

CLG promotes mTOR/ULK1 pathway‐mediated autophagy to inhibit OS development by inhibiting TRAF6‐mediated FLT3 ubiquitination.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3466, doi. 10.1111/cas.16274

By:

Huang, Xiongjie;
Huang, Yanran;
Peng, Bin;
Wang, Junfang;
Tang, Huiyu;
Chen, Yanming

Publication type:

Article

Unveiling hierarchy and spatial distribution of O<sup>6</sup>‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3403, doi. 10.1111/cas.16268

By:

Li, Mingxiao;
Liu, Jiang;
Weng, Jiancong;
Dong, Gehong;
Chen, Xuzhu;
Cui, Yong;
Ren, Xiaohui;
Shen, Shaoping;
Jiang, Haihui;
Zhang, Xiaokang;
Zhao, Xuzhe;
Li, Ming;
Wang, Xijie;
Ren, Hongxiang;
Li, Qiang;
Zhang, Yulian;
Cheng, Quan;
Yu, Yanbing;
Lin, Song

Publication type:

Article

Clinicopathological, molecular, and prognostic features of colorectal carcinomas with KRAS c.34G>T (p.G12C) mutation.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3455, doi. 10.1111/cas.16262

By:

Ugai, Satoko;
Yao, Qian;
Takashima, Yasutoshi;
Zhong, Yuxue;
Matsuda, Kosuke;
Kawamura, Hidetaka;
Imamura, Yu;
Okadome, Kazuo;
Mima, Kosuke;
Arima, Kota;
Kosumi, Keisuke;
Song, Mingyang;
Meyerhardt, Jeffrey A.;
Giannakis, Marios;
Nowak, Jonathan A.;
Ugai, Tomotaka;
Ogino, Shuji

Publication type:

Article

Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3218, doi. 10.1111/cas.16266

By:

Waki, Kayoko;
Ozawa, Miyako;
Ohta, Keisuke;
Komatsu, Nobukazu;
Yamada, Akira

Publication type:

Article

CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3273, doi. 10.1111/cas.16264

By:

Huang, Yongjie;
Wei, Xinyi;
Tu, Mengyan;
Lu, Weiguo;
Xu, Junfen

Publication type:

Article

NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3256, doi. 10.1111/cas.16249

By:

Xue, Ziyi;
Xie, Haijing;
Shan, Ying;
Zhang, Lin;
Cheng, Lin;
Chen, Wenyue;
Zhu, Rui;
Zhang, Kaiwen;
Ni, Haosheng;
Zhang, Zhenxin;
You, Yiwen;
You, Bo

Publication type:

Article

Accurate predictors of immune checkpoint inhibitors in patients with gallbladder cancer.

Published in:

Cancer Science, 2024, v. 115, n. 10, p. 3481, doi. 10.1111/cas.16235

By:

Li, Naimei;
Deng, Shuang

Publication type:

Article

Issue Information.

Published in:: Cancer Science, 2024, v. 115, n. 10, p. 3201, doi. 10.1111/cas.15866
Publication type:: Article